Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-13

Clinical Trial Update: MRE Predictors of Disease Relapse After Stopping Biologics

View source ↗

Summary

A recruiting study from University College London investigates MRE-based predictors of relapse in Crohn's disease after stopping biologic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University College, London | Conditions: Crohn's Disease | Status: RECRUITING